SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000930413-12-001600
Filing Date
2012-03-16
Accepted
2012-03-16 15:29:08
Documents
1
Period of Report
2012-03-15

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT c68946_form4.html 4  
1 OWNERSHIP DOCUMENT c68946_form4.xml 4 3581
  Complete submission text file 0000930413-12-001600.txt   5322
Mailing Address 20 KINGSBRIDGE ROAD ATT: GENERAL COUNSEL PISCATAWAY NJ 08854
Business Address 20 KINGSBRIDGE ROAD ATT: GENERAL COUNSEL PISCATAWAY NJ 08854 732-980-4500
ENZON PHARMACEUTICALS INC (Issuer) CIK: 0000727510 (see all company filings)

IRS No.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ENZON PHARMACEUITCALS, INC. 685 ROUTE 202/206 BRIDGEWATER NJ 08807
Business Address
Young Richard A (Reporting) CIK: 0001490283 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-12957 | Film No.: 12697538